In order to elucidate the process by which decanoylcarnitine (acylcarnitine), a diagnostic marker for RCC, is regulated by intracellular CPT1, we validated the expression of CPT family members (CPT1A, CPT1B, CPT2, SLC25A20, and CrAT) using databases and ELISA (Figure 5). This evidence concerns the gene CPT1A and renal cell carcinoma.